Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The incidence of adverse pulmonary reactions to mitomycin was low

    • 3 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    The incidence of adverse pulmonary reactions to mitomycin was low. React. Wkly. 599, 4 (1996). https://doi.org/10.2165/00128415-199605990-00012

    Download citation

    Keywords

    • Public Health
    • Carcinoma
    • Cell Carcinoma
    • Squamous Cell Carcinoma
    • Squamous Cell